R-spondin-2 is a Wnt agonist that regulates osteoblast activity and bone mass

M Noelle Knight1, Kannan Karuppaiah2, Michele Lowe2

  • 11Department of Orthopaedic Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

Bone Research
|August 23, 2018
PubMed

Insights

R-spondin-2 (RSPO2) is crucial for bone formation. Disrupting RSPO2 in osteoblasts reduces bone mass and impairs mineralization, highlighting its role in postnatal bone development.

Area of Science:

  • Bone Biology
  • Skeletal Development
  • Cell Signaling

Background:

  • R-spondin proteins are Wnt agonists involved in skeletal development.
  • R-spondin-2 (RSPO2) is expressed in osteoblasts and promotes osteoblast differentiation.
  • The role of RSPO2 in postnatal bone formation remains unexplored.

Purpose of the Study:

  • To investigate the role of RSPO2 in postnatal osteoblastogenesis and bone formation.
  • To determine the impact of RSPO2 deficiency on bone mass and skeletal development.

Main Methods:

  • In vitro studies using limb-bud progenitor cells from Rspo2 knockout mice.
  • Generation of Rspo2 conditional knockout mice (Ocn-Cre+Rspo2floxed).
  • Histomorphometric analysis, serum osteocalcin measurements, and gene expression analysis.

Main Results:

  • Rspo2 knockout progenitor cells show reduced mineralization and altered osteogenic gene expression.
  • Ocn-Cre+Rspo2floxed mice exhibit decreased body size and bone mass.
  • Reduced mineral apposition and bone formation rates, decreased serum osteocalcin, and impaired beta-catenin signaling were observed.

Conclusions:

  • RSPO2 is essential for regulating osteoblastogenesis and mineralization in postnatal bone.
  • RSPO2 deficiency leads to reduced bone mass and impaired skeletal development.
  • RSPO2 plays a critical role in maintaining bone homeostasis through beta-catenin signaling.

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.9K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.2K
Enteric Nervous System: Regulation of GI Motor Activity01:11

Enteric Nervous System: Regulation of GI Motor Activity

The Enteric Nervous System (ENS) plays a pivotal role in regulating gastrointestinal or GI motor activity. This complex network of nerves, deeply embedded within the gut wall, responds to changes in the gut environment and receives input from both the autonomic nervous system and the central nervous system. By doing so, the ENS operates various programs tailored to the body's nutritional status and needs.
During periods of fasting, the ENS initiates the migrating myoelectric complex, a...
1.9K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.6K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
996